ES2225524T5 - Procedimiento para la purificacion de una sal de acido clavulanico. - Google Patents

Procedimiento para la purificacion de una sal de acido clavulanico. Download PDF

Info

Publication number
ES2225524T5
ES2225524T5 ES01925753T ES01925753T ES2225524T5 ES 2225524 T5 ES2225524 T5 ES 2225524T5 ES 01925753 T ES01925753 T ES 01925753T ES 01925753 T ES01925753 T ES 01925753T ES 2225524 T5 ES2225524 T5 ES 2225524T5
Authority
ES
Spain
Prior art keywords
salt
clavulanic acid
medium
amine
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES01925753T
Other languages
English (en)
Spanish (es)
Other versions
ES2225524T3 (es
Inventor
Guo Zhang
John Mcknight
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26244256&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2225524(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0011519A external-priority patent/GB0011519D0/en
Priority claimed from GB0011521A external-priority patent/GB0011521D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Application granted granted Critical
Publication of ES2225524T3 publication Critical patent/ES2225524T3/es
Publication of ES2225524T5 publication Critical patent/ES2225524T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
ES01925753T 2000-05-13 2001-05-09 Procedimiento para la purificacion de una sal de acido clavulanico. Expired - Lifetime ES2225524T5 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0011519A GB0011519D0 (en) 2000-05-13 2000-05-13 Process
GB0011521 2000-05-13
GB0011519 2000-05-13
GB0011521A GB0011521D0 (en) 2000-05-13 2000-05-13 Process

Publications (2)

Publication Number Publication Date
ES2225524T3 ES2225524T3 (es) 2005-03-16
ES2225524T5 true ES2225524T5 (es) 2009-03-01

Family

ID=26244256

Family Applications (1)

Application Number Title Priority Date Filing Date
ES01925753T Expired - Lifetime ES2225524T5 (es) 2000-05-13 2001-05-09 Procedimiento para la purificacion de una sal de acido clavulanico.

Country Status (23)

Country Link
US (1) US7767823B2 (enExample)
EP (1) EP1284978B2 (enExample)
JP (1) JP4954421B2 (enExample)
KR (1) KR100827898B1 (enExample)
CN (1) CN1222528C (enExample)
AT (1) ATE273982T1 (enExample)
AU (1) AU776184B2 (enExample)
BR (1) BRPI0110774B8 (enExample)
CA (1) CA2408853C (enExample)
CZ (1) CZ304775B6 (enExample)
DE (1) DE60105016T3 (enExample)
DK (1) DK1284978T4 (enExample)
ES (1) ES2225524T5 (enExample)
HU (1) HU228593B1 (enExample)
IL (2) IL152643A0 (enExample)
MX (1) MXPA02011192A (enExample)
NO (1) NO328528B1 (enExample)
NZ (1) NZ522414A (enExample)
PL (1) PL206316B1 (enExample)
PT (1) PT1284978E (enExample)
SI (1) SI1284978T2 (enExample)
WO (1) WO2001087891A1 (enExample)
ZA (1) ZA200209141B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1284978E (pt) 2000-05-13 2004-12-31 Smithkline Beecham Plc Processo para a purificacao de um sal de acido clavulanico
CN105384758B (zh) * 2015-12-01 2018-05-01 国药集团威奇达药业有限公司 克拉维酸胺盐的制备方法
JP2019527214A (ja) 2016-07-14 2019-09-26 アカオジェン インコーポレイテッド 細菌感染症の処置における使用のためのセフチブテンとクラブラン酸の組み合わせ
CN109305978A (zh) * 2017-07-26 2019-02-05 山东睿鹰先锋制药有限公司 一种制备克拉维酸盐的新方法
CN109535184B (zh) * 2017-09-21 2020-11-20 联邦制药(内蒙古)有限公司 一种克拉维酸叔辛胺制备克拉维酸钾的方法
CN108558909B (zh) * 2018-05-17 2019-09-17 国药集团威奇达药业有限公司 综合回收克拉维酸叔丁胺盐结晶母液中有效成分的方法
KR20220031043A (ko) 2019-07-05 2022-03-11 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 스트렙토미세스 클라불리게루스

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1299883A (fr) 1961-09-06 1962-07-27 Pfizer & Co C Perfectionnements apportés aux procédés pour séparer des amino-acides amphotères de leurs solutions aqueuses
GB1508977A (en) 1974-04-20 1978-04-26 Beecham Group Ltd Beta-lactam antibiotic from streptomyces clavuligerus
GB2003863B (en) 1977-09-01 1982-03-31 Beecham Group Ltd Chemical process
EP0026044B1 (en) * 1979-08-24 1983-06-08 Beecham Group Plc Amine salt of clavulanic acid, its preparation and use
US4449182A (en) * 1981-10-05 1984-05-15 Digital Equipment Corporation Interface between a pair of processors, such as host and peripheral-controlling processors in data processing systems
MX7417E (es) 1984-10-27 1988-10-14 Antibioticos Sa Metodo para la preparacion de acido clavulanico y sus derivados
ES2074048T3 (es) 1987-01-29 1995-09-01 Beecham Group Plc Procedimiento para la cristalizacion de clavulanato de potasio.
GB2204944B (en) 1987-05-18 1991-10-02 Frederick John Anderson Rechargeable light
DE3729338A1 (de) 1987-09-02 1989-03-23 Biotechnolog Forschung Gmbh Verfahren zur abtrennung von penicillin g aus einem fermentationsmedium durch extraktion
US5318896A (en) 1991-09-11 1994-06-07 Merck & Co., Inc. Recombinant expandase bioprocess for preparing 7-aminodesacetoxy cephalosporanic acid (7-ADCA)
KR100227711B1 (ko) 1991-10-15 1999-12-01 한스 발터 라벤 7-아미노세팔로스포란산 및 7-아미노데아세틸세팔로스포란산 제조를 위한 신규한 생물학적 공정
AT400033B (de) * 1992-03-10 1995-09-25 Biochemie Gmbh Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben
SI9300296B (sl) 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
KR100200239B1 (ko) * 1992-10-21 1999-06-15 김충환 클라불란산 칼륨염의 제조방법
GB9305565D0 (en) 1993-03-18 1993-05-05 Smithkline Beecham Plc Novel compounds and processes
US5821364A (en) * 1993-03-26 1998-10-13 Gist-Brocades N.V. Diamine salts of clavulanic acid
WO1995004148A1 (en) 1993-07-30 1995-02-09 Gist-Brocades B.V. Process for the efficient production of 7-adca via 2-(carboxyethylthio)acetyl-7-adca and 3-(carboxymethylthio)propionyl-7-adca
AT400846B (de) 1994-02-25 1996-03-25 Fermic S A De C V Verfahren zur gewinnung und reinigung von alkalimetallsalzen der clavulansäure
SI9400107A (en) 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
GB9426261D0 (en) 1994-12-24 1995-02-22 Spurcourt Ltd Clavulanic acid salts
SI9500074A (en) 1995-03-10 1996-10-31 Lek Tovarna Farmacevtskih Process for preparation of alkani salts of clavulanic acid.
SI9500134B (sl) 1995-04-20 2004-04-30 Lek, Postopek za pripravo čistih alkalijskih soli klavulanske kisline
KR100200242B1 (ko) 1995-05-16 1999-06-15 김충환 클라불란산염의 제조 방법
WO1997005143A1 (en) * 1995-07-25 1997-02-13 Asahi Kasei Kogyo Kabushiki Kaisha Novel group 4 transition metal compounds
GB9515809D0 (en) * 1995-08-02 1995-10-04 Smithkline Beecham Plc Process
BR9713339A (pt) * 1996-11-11 2000-05-09 Gist Brocades Bv Processo para preparação de sais e ésteres do ácido clavulânico.
AT404728B (de) * 1996-11-27 1999-02-25 Biochemie Gmbh Verfahren zur herstellung von clavulansäure-aminsalzen
WO1998042858A1 (en) * 1997-03-24 1998-10-01 Cipan-Companhia Industrial Produtora De Antibióticos, S.A. Process for the isolation of a pharmaceutically acceptable alkali metal salt of clavulanic acid
RO120653B1 (ro) * 1997-04-22 2006-05-30 Gist-Brocades B.V. Procedeu îmbunătăţit pentru preparare de cefalosporine
CA2337072A1 (en) * 1998-07-16 2000-01-27 Dsm N.V. Improved process for the preparation of salts and esters of clavulanic acid
PT1284978E (pt) 2000-05-13 2004-12-31 Smithkline Beecham Plc Processo para a purificacao de um sal de acido clavulanico

Also Published As

Publication number Publication date
BRPI0110774B8 (pt) 2021-05-25
PL206316B1 (pl) 2010-07-30
ZA200209141B (en) 2003-12-31
NO328528B1 (no) 2010-03-08
WO2001087891A1 (en) 2001-11-22
SI1284978T2 (sl) 2008-12-31
CZ20023723A3 (cs) 2003-05-14
IL152643A (en) 2012-12-31
NZ522414A (en) 2004-05-28
BRPI0110774B1 (pt) 2015-07-07
CA2408853C (en) 2012-01-10
MXPA02011192A (es) 2003-03-10
DE60105016D1 (de) 2004-09-23
ATE273982T1 (de) 2004-09-15
KR100827898B1 (ko) 2008-05-07
JP4954421B2 (ja) 2012-06-13
CN1222528C (zh) 2005-10-12
HUP0300869A3 (en) 2003-10-28
DE60105016T3 (de) 2009-06-25
EP1284978A1 (en) 2003-02-26
CA2408853A1 (en) 2001-11-22
DK1284978T4 (da) 2009-01-05
IL152643A0 (en) 2003-06-24
PT1284978E (pt) 2004-12-31
AU5243201A (en) 2001-11-26
HU228593B1 (en) 2013-04-29
AU776184B2 (en) 2004-09-02
NO20025422D0 (no) 2002-11-12
US20060079676A1 (en) 2006-04-13
CZ304775B6 (cs) 2014-10-15
JP2003533529A (ja) 2003-11-11
DE60105016T2 (de) 2005-08-18
NO20025422L (no) 2003-01-07
EP1284978B2 (en) 2008-09-10
US7767823B2 (en) 2010-08-03
ES2225524T3 (es) 2005-03-16
HK1055111A1 (en) 2003-12-24
PL358368A1 (en) 2004-08-09
CN1429227A (zh) 2003-07-09
DK1284978T3 (da) 2004-12-13
BR0110774A (pt) 2003-05-13
KR20030014222A (ko) 2003-02-15
SI1284978T1 (en) 2005-02-28
HUP0300869A2 (hu) 2003-08-28
EP1284978B1 (en) 2004-08-18

Similar Documents

Publication Publication Date Title
FI67222B (fi) Foerfarande foer rening av klavulansyra och saosom mellanprodukt anvaendbara aminsalt av klavulansyra samt foerfarande foer framstaellning av dessa
JP2010013458A (ja) クラブラン酸カリウムの製造方法
ES2225524T5 (es) Procedimiento para la purificacion de una sal de acido clavulanico.
KR100200242B1 (ko) 클라불란산염의 제조 방법
RU2387656C2 (ru) Способ получения гидробромида галантамина
JPH11501023A (ja) クラブラン酸塩
JP2004043462A (ja) 精製方法
PL188634B1 (pl) Sposób wytwarzania potasowej soli kwasu klawulanowego
HK1055111B (en) Process for the purification of a salt of clavulanic acid
SK4522003A3 (en) Method of purifying pravastatin or its pharmacologically acceptable salt
US4610986A (en) Aminonaphthacene derivatives and their production
US6355802B1 (en) Process to prepare (5R)-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]-quinolin-2(1h)-one
US6121306A (en) Method of making (1S, 4R)-1-azabicyclo[2.2.1]heptan-3-one and (1R, 4S), 1-azabicyclo[2.2.1]heptan-3-one
ISAKA et al. Lactol esters of ampicillin
RU2135502C1 (ru) Диаминовые соли клавулановой кислоты, способ их получения (варианты), способ получения клавулановой кислоты или ее фармацевтически приемлемой соли, способ очистки клавулановой кислоты или ее соли
JPS63104969A (ja) 含硫黄複素環化合物
PT88663B (pt) Processo para a preparacao de monohidrato e solvatos de um novo antibiotico de beta-lactamo
PL172021B1 (pl) Sposób oczyszczania kwasu klawulanowego PL
伊坂一郎 et al. Lactol esters of ampicillin.
JPH0570458A (ja) ピロロキノリンキノン誘導体
RU97115880A (ru) Соли клавулановой кислоты
JPH06145171A (ja) ピロロキノリンキノンの製造方法